Compare Sanofi SA (SNY) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Sanofi SA trades at $40.04 (market cap $95.18B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $213.71 (market cap $39.15B). The key difference: Sanofi SA is far larger — about 2.4× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and Sanofi SA pays a 6.01% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days on average.
| SNY | TTWO | |
|---|---|---|
Market Cap | $95.18B | $39.15B |
Volume | 2,995,646 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $52.34 | $262.29 |
52-Week Low | $39.51 | $189.69 |
Typical Hold Time | 94 Days | 111 Days |
Enterprise Value | $114.48B | $40.27B |
Dividend Yield | 6.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
Take-Two Interactive (TTWO) trades at $213.44, up 4.62% today, showing strong momentum ahead of GTA VI's November launch. The stock maintains a bullish technical signal with support at $206 and resistance at $215. Despite recent earnings volatility with a Q2 miss, analyst consensus remains overwhelmingly positive with 79% buy ratings and a $292.30 price target, representing 37% upside potential from current levels.
While TTWO faces fundamental challenges with negative net margins and elevated debt levels, the imminent GTA VI release provides significant catalyst potential. Investors should weigh the substantial growth opportunity against execution risks and current valuation metrics that price in successful game performance. The stock's trajectory will likely hinge on GTA VI's commercial success and the company's ability to return to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
